COR vs MCK: fair value comparison
Cencora, Inc. and McKesson Corporation · Updated 2026-09-07
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, COR currently sits closer to the top of our discount ranking.
| COR | MCK | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $330.95 | $907.99 |
| 12-month range | $264.69–$372.65 | $734.82–$990.95 |
| Sector rank | #75 of 113 Healthcare | #80 of 113 Healthcare |
| Quality grade | F | F |
| Leverage | High | Low |
| Margin trend | Stable | Stable |
| Revenue growth | Strong | Strong |
| RSI zone | Neutral | Neutral |
| DCF cross-check | — | Undervalued |
| 52-week position | The upper-middle quarter | The upper-middle quarter |
Full single-stock breakdowns: COR fair value analysis · MCK fair value analysis